The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant <named-content content-type="genus-species">Staphylococcus aureus</named-content>
ABSTRACT Resistance or tolerance to traditional antibiotics is a challenging issue in antimicrobial chemotherapy. Moreover, traditional bactericidal antibiotics kill only actively growing bacterial cells, whereas nongrowing metabolically inactive cells are tolerant to and therefore “persist” in the...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
American Society for Microbiology
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4c6e5367321845828598c4354294512c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:4c6e5367321845828598c4354294512c |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:4c6e5367321845828598c4354294512c2021-11-15T15:56:46ZThe Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant <named-content content-type="genus-species">Staphylococcus aureus</named-content>10.1128/mBio.01140-202150-7511https://doaj.org/article/4c6e5367321845828598c4354294512c2020-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01140-20https://doaj.org/toc/2150-7511ABSTRACT Resistance or tolerance to traditional antibiotics is a challenging issue in antimicrobial chemotherapy. Moreover, traditional bactericidal antibiotics kill only actively growing bacterial cells, whereas nongrowing metabolically inactive cells are tolerant to and therefore “persist” in the presence of legacy antibiotics. Here, we report that the diarylurea derivative PQ401, previously characterized as an inhibitor of the insulin-like growth factor I receptor, kills both antibiotic-resistant and nongrowing antibiotic-tolerant methicillin-resistant Staphylococcus aureus (MRSA) by lipid bilayer disruption. PQ401 showed several beneficial properties as an antimicrobial lead compound, including rapid killing kinetics, low probability for resistance development, high selectivity to bacterial membranes compared to mammalian membranes, and synergism with gentamicin. In contrast to well-studied membrane-disrupting cationic antimicrobial low-molecular-weight compounds and peptides, molecular dynamic simulations supported by efficacy data demonstrate that the neutral form of PQ401 penetrates and subsequently embeds into bacterial lipid bilayers more effectively than the cationic form. Lastly, PQ401 showed efficacy in both the Caenorhabditis elegans and Galleria mellonella models of MRSA infection. These data suggest that PQ401 may be a lead candidate for repurposing as a membrane-active antimicrobial and has potential for further development as a human antibacterial therapeutic for difficult-to-treat infections caused by both drug-resistant and -tolerant S. aureus. IMPORTANCE Membrane-damaging antimicrobial agents have great potential to treat multidrug-resistant or multidrug-tolerant bacteria against which conventional antibiotics are not effective. However, their therapeutic applications are often hampered due to their low selectivity to bacterial over mammalian membranes or their potential for cross-resistance to a broad spectrum of cationic membrane-active antimicrobial agents. We discovered that the diarylurea derivative compound PQ401 has antimicrobial potency against multidrug-resistant and multidrug-tolerant Staphylococcus aureus. PQ401 selectively disrupts bacterial membrane lipid bilayers in comparison to mammalian membranes. Unlike cationic membrane-active antimicrobials, the neutral form of PQ401 rather than its cationic form exhibits maximum membrane activity. Overall, our results demonstrate that PQ401 could be a promising lead compound that overcomes the current limitations of membrane selectivity and cross-resistance. Also, this work provides deeper insight into the design and development of new noncharged membrane-targeting therapeutics to combat hard-to-cure bacterial infections.Wooseong KimGuijin ZouWen PanNico FrickeHammad A. FaiziSoo Min KimRajamohammed KhaderSilei LiKiho LeeIliana EscorbaPetia M. VlahovskaHuajian GaoFrederick M. AusubelEleftherios MylonakisAmerican Society for Microbiologyarticlepersistersantibiotic toleranceantimicrobial resistanceMRSAmembrane-active antimicrobialsantibioticMicrobiologyQR1-502ENmBio, Vol 11, Iss 3 (2020) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
persisters antibiotic tolerance antimicrobial resistance MRSA membrane-active antimicrobials antibiotic Microbiology QR1-502 |
| spellingShingle |
persisters antibiotic tolerance antimicrobial resistance MRSA membrane-active antimicrobials antibiotic Microbiology QR1-502 Wooseong Kim Guijin Zou Wen Pan Nico Fricke Hammad A. Faizi Soo Min Kim Rajamohammed Khader Silei Li Kiho Lee Iliana Escorba Petia M. Vlahovska Huajian Gao Frederick M. Ausubel Eleftherios Mylonakis The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant <named-content content-type="genus-species">Staphylococcus aureus</named-content> |
| description |
ABSTRACT Resistance or tolerance to traditional antibiotics is a challenging issue in antimicrobial chemotherapy. Moreover, traditional bactericidal antibiotics kill only actively growing bacterial cells, whereas nongrowing metabolically inactive cells are tolerant to and therefore “persist” in the presence of legacy antibiotics. Here, we report that the diarylurea derivative PQ401, previously characterized as an inhibitor of the insulin-like growth factor I receptor, kills both antibiotic-resistant and nongrowing antibiotic-tolerant methicillin-resistant Staphylococcus aureus (MRSA) by lipid bilayer disruption. PQ401 showed several beneficial properties as an antimicrobial lead compound, including rapid killing kinetics, low probability for resistance development, high selectivity to bacterial membranes compared to mammalian membranes, and synergism with gentamicin. In contrast to well-studied membrane-disrupting cationic antimicrobial low-molecular-weight compounds and peptides, molecular dynamic simulations supported by efficacy data demonstrate that the neutral form of PQ401 penetrates and subsequently embeds into bacterial lipid bilayers more effectively than the cationic form. Lastly, PQ401 showed efficacy in both the Caenorhabditis elegans and Galleria mellonella models of MRSA infection. These data suggest that PQ401 may be a lead candidate for repurposing as a membrane-active antimicrobial and has potential for further development as a human antibacterial therapeutic for difficult-to-treat infections caused by both drug-resistant and -tolerant S. aureus. IMPORTANCE Membrane-damaging antimicrobial agents have great potential to treat multidrug-resistant or multidrug-tolerant bacteria against which conventional antibiotics are not effective. However, their therapeutic applications are often hampered due to their low selectivity to bacterial over mammalian membranes or their potential for cross-resistance to a broad spectrum of cationic membrane-active antimicrobial agents. We discovered that the diarylurea derivative compound PQ401 has antimicrobial potency against multidrug-resistant and multidrug-tolerant Staphylococcus aureus. PQ401 selectively disrupts bacterial membrane lipid bilayers in comparison to mammalian membranes. Unlike cationic membrane-active antimicrobials, the neutral form of PQ401 rather than its cationic form exhibits maximum membrane activity. Overall, our results demonstrate that PQ401 could be a promising lead compound that overcomes the current limitations of membrane selectivity and cross-resistance. Also, this work provides deeper insight into the design and development of new noncharged membrane-targeting therapeutics to combat hard-to-cure bacterial infections. |
| format |
article |
| author |
Wooseong Kim Guijin Zou Wen Pan Nico Fricke Hammad A. Faizi Soo Min Kim Rajamohammed Khader Silei Li Kiho Lee Iliana Escorba Petia M. Vlahovska Huajian Gao Frederick M. Ausubel Eleftherios Mylonakis |
| author_facet |
Wooseong Kim Guijin Zou Wen Pan Nico Fricke Hammad A. Faizi Soo Min Kim Rajamohammed Khader Silei Li Kiho Lee Iliana Escorba Petia M. Vlahovska Huajian Gao Frederick M. Ausubel Eleftherios Mylonakis |
| author_sort |
Wooseong Kim |
| title |
The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant <named-content content-type="genus-species">Staphylococcus aureus</named-content> |
| title_short |
The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant <named-content content-type="genus-species">Staphylococcus aureus</named-content> |
| title_full |
The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant <named-content content-type="genus-species">Staphylococcus aureus</named-content> |
| title_fullStr |
The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant <named-content content-type="genus-species">Staphylococcus aureus</named-content> |
| title_full_unstemmed |
The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant <named-content content-type="genus-species">Staphylococcus aureus</named-content> |
| title_sort |
neutrally charged diarylurea compound pq401 kills antibiotic-resistant and antibiotic-tolerant <named-content content-type="genus-species">staphylococcus aureus</named-content> |
| publisher |
American Society for Microbiology |
| publishDate |
2020 |
| url |
https://doaj.org/article/4c6e5367321845828598c4354294512c |
| work_keys_str_mv |
AT wooseongkim theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT guijinzou theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT wenpan theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT nicofricke theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT hammadafaizi theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT soominkim theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT rajamohammedkhader theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT sileili theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT kiholee theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT ilianaescorba theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT petiamvlahovska theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT huajiangao theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT frederickmausubel theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT eleftheriosmylonakis theneutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT wooseongkim neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT guijinzou neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT wenpan neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT nicofricke neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT hammadafaizi neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT soominkim neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT rajamohammedkhader neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT sileili neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT kiholee neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT ilianaescorba neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT petiamvlahovska neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT huajiangao neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT frederickmausubel neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent AT eleftheriosmylonakis neutrallychargeddiarylureacompoundpq401killsantibioticresistantandantibiotictolerantnamedcontentcontenttypegenusspeciesstaphylococcusaureusnamedcontent |
| _version_ |
1718427086248476672 |